Krishna Institute Of Medical Science (KIMS) (NSE: KIMS, BSE: 543308) is a Secunderabad, Telangana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹26,793 Cr, it ranks #296 by market cap among the 6,189 Indian listed companies on FinBizNet, and #7 of 42 in Hospitals and Healthcare Centers. At ₹691.55 (as of 27 Oct 2026), the share price is 19.4% below its 52-week high of ₹858.00 and 20.1% above its 52-week low of ₹575.80. The share price is down 7.3% over one year and down 16.7% over three months.
| Current Price | ₹691.55 |
|---|---|
| Market Cap | ₹26,793 Cr |
| NSE Symbol | KIMS |
| BSE Code | 543308 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 111 |
| Return on Equity | 9.72% |
| Return on Assets | 4.83% |
| 52-Week Range | ₹575.80 – ₹858.00 |
| 1-Year Price Change | -7.3% |
| 3-Month Price Change | -16.7% |
| Beta (1Y) | 0.68 |
| Headquarters | Secunderabad, Telangana |
| Website | www.kimshospitals.com |
| Revenue | ₹1,180 Cr |
|---|---|
| Net Profit | ₹36 Cr |
| Net Margin | 3.1% |
| EPS (Basic) | ₹1.04 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interven
1. Medical and Healthcare Services-This segment provides medical and healthcare services. 2. Electricity Sales-0 3. Un-Allocable Corporate Assets-0
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,12,785 Cr | 58.1 | 21.50% | ₹7,044 Cr | -0.7% |
| Manipal Health Enterprises Ltd | ₹82,040 Cr | 81.3 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹81,271 Cr | 56.6 | 14.33% | ₹2,366 Cr | -30.6% |
| Aster Dm Healthcare Limited (Asterdm) | ₹56,321 Cr | 86 | 10.07% | ₹1,311 Cr | -6.8% |
| Fortis Healthcare Ltd. | ₹55,467 Cr | 53.2 | 11.01% | ₹2,545 Cr | -32.3% |
| Global Health Ltd (Medanta) | ₹32,587 Cr | 58.7 | 15.03% | ₹1,304 Cr | -11.7% |
| Krishna Institute Of Medical Science (KIMS) | ₹26,793 Cr | 111 | 9.72% | ₹1,180 Cr | -7.3% |
| Dr. Agarwal's Health Care Limited | ₹15,067 Cr | 113.7 | 8.31% | ₹614 Cr | -12.3% |
| Rainbow Children'S Medicare Limited | ₹11,802 Cr | 42.4 | 17.94% | ₹470 Cr | -11.4% |
Listed by market capitalisation. Ratios are shown for context only.
Krishna Institute Of Medical Science (KIMS) is trading at ₹691.55, with a market capitalisation of ₹26,793 Cr.
Krishna Institute Of Medical Science (KIMS) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Krishna Institute Of Medical Science (KIMS) has a P/E of 111 and a return on equity of 9.72%.
Krishna Institute Of Medical Science (KIMS) is listed on the NSE under the symbol KIMS and on the BSE under the scrip code 543308.
Krishna Institute Of Medical Science (KIMS)'s share price is down 7.3% over one year and down 16.7% over three months. Its 52-week range is ₹575.80 to ₹858.00.
In Q1 FY27, Krishna Institute Of Medical Science (KIMS) reported revenue of ₹1,180 Cr and net profit of ₹36 Cr, with basic EPS of ₹1.04 (consolidated, parsed from the company's exchange filing).
Data as of 27 Oct 2026. Descriptive market data only — not investment advice.